Location
Canada, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Enterprise
Future of Education and Work
About Investor
Dennis Kavelman is a Partner at Inovia Capital, deploying growth-stage capital in biotech, enterprise, health IT, digital health and future‑of‑work ventures, typically writing $100K–$5M checks. His most recent investment was in Guesty. He previously held executive roles at RIM (as CFO/COO) and Desire2Learn (as COO), and also earlier worked at KPMG.
Previous investments
BenchSci
70M |2023
50M |2022
22M |2020
WorkJam
50M |2022
50M |2020
Symend
43M |2021
52M |2020
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free